[1]
Nieto-Ríos, J.F., Aristizabal-Alzate, A., Ocampo-Kohn, C., Vanegas-Ruiz, J.J., Vélez-Echeverri, C., Serna-Higuita, L.M., Aguirre, D.C., Yepes-Delgado, C.E. and Zuluaga-Valencia, G. 2014. Low incidence of lymphoproliferative disease post kidney transplantation with prevalent use of alemtuzumab. Revista de Nefrología, Diálisis y Trasplante. 34, 1 (Jan. 2014), 21-26.